Tinnitech International is an Italian start-up founded by a group of high-profile investors and managers who have developed a ground-breaking device delivering the first multiple therapy to treat tinnitus (clinically defined as “synchronous multimodal therapy”) based on a versatile, effective and long-lasting remedy.
Our members
Investor, Medical Sector “Fin Posillipo S.p.A. – holding company of the Petrone group. The company operates globally in the field of pharmaceutical distribution and production. With a turnover of about 537 million, it has a direct presence on the national market of Italy, in Spain, Ireland, Singapore, the United States, Germany and Portugal.”
Financial holding investor, medical sector Over 40 years of activity in the export and distribution of pharmaceutical products on a European scale; purchase of pharmaceutical molecules, research and development of food supplements. Turnover of 250 million, 300 between employees and advisors, 50,000 square metres of warehousing.
Pier Vincenzo Colli
Investor Manager 40 years of experience within Healthcare & Pharma companies. He has held top positions in multinationals such as IQVIA, PHARMACIA-UPJHON, NYCOMED, TAKEDA.
For the last 10 years he has been CEO of leading Italian group ALFASIGMA. He is currently a strategic consultant and private equity investor in the Healthcare/Biopharmaceutical sector.